BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28034988)

  • 1. The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.
    Gaynes JS; Jonart LM; Zamora EA; Naumann JA; Gossai NP; Gordon PM
    Haematologica; 2017 Apr; 102(4):e136-e139. PubMed ID: 28034988
    [No Abstract]   [Full Text] [Related]  

  • 2. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioimaging analysis of nuclear factor-κB activity in Philadelphia chromosome-positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor-α-stimulated changes to the microenvironment.
    Tsai HJ; Kobayashi S; Izawa K; Ishida T; Watanabe T; Umezawa K; Lin SF; Tojo A
    Cancer Sci; 2011 Nov; 102(11):2014-21. PubMed ID: 21777350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
    Boyerinas B; Zafrir M; Yesilkanal AE; Price TT; Hyjek EM; Sipkins DA
    Blood; 2013 Jun; 121(24):4821-31. PubMed ID: 23589674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BACH2-mediated FOS confers cytarabine resistance via stromal microenvironment alterations in pediatric ALL.
    Zhang H; Zhang R; Zheng X; Sun M; Fan J; Fang C; Tian X; Zheng H
    Cancer Sci; 2021 Mar; 112(3):1235-1250. PubMed ID: 33393145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
    Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
    Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS).
    Krause S; Pfeiffer C; Strube S; Alsadeq A; Fedders H; Vokuhl C; Loges S; Waizenegger J; Ben-Batalla I; Cario G; Möricke A; Stanulla M; Schrappe M; Schewe DM
    Blood; 2015 Jan; 125(5):820-30. PubMed ID: 25428221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy.
    Gopalakrishnapillai A; Kolb EA; Dhanan P; Mason RW; Napper A; Barwe SP
    PLoS One; 2015; 10(10):e0140564. PubMed ID: 26465153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia propagating cells rebuild an evolving niche in response to therapy.
    Duan CW; Shi J; Chen J; Wang B; Yu YH; Qin X; Zhou XC; Cai YJ; Li ZQ; Zhang F; Yin MZ; Tao Y; Mi JQ; Li LH; Enver T; Chen GQ; Hong DL
    Cancer Cell; 2014 Jun; 25(6):778-93. PubMed ID: 24937459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
    Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
    Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
    Uy GL; Hsu YM; Schmidt AP; Stock W; Fletcher TR; Trinkaus KM; Westervelt P; DiPersio JF; Link DC
    Leuk Res; 2015 Dec; 39(12):1437-42. PubMed ID: 26467815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
    Pillozzi S; Masselli M; De Lorenzo E; Accordi B; Cilia E; Crociani O; Amedei A; Veltroni M; D'Amico M; Basso G; Becchetti A; Campana D; Arcangeli A
    Blood; 2011 Jan; 117(3):902-14. PubMed ID: 21048156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.
    Alexander PM; Caudell DL; Kucera GL; Pladna KM; Pardee TS
    PLoS One; 2017; 12(6):e0179798. PubMed ID: 28644853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
    Xu B; Song X; Yip NC; Xiao P; Zhang Y; Wang W; Zhou S
    Hematology; 2010 Apr; 15(2):74-80. PubMed ID: 20423567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia.
    Lönnerholm G; Thörn I; Sundström C; Frost BM; Flaegstad T; Heyman M; Jonsson OG; Harila-Saari A; Madsen HO; Porwit A; Schmiegelow K; Söderhäll S; Wesenberg F; Vettenranta K; Larsson R; Forestier E
    Leuk Res; 2011 Apr; 35(4):472-8. PubMed ID: 20961616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of resistance and therapeutic prospect of leukemia mediated by signaling pathway in bone marrow microenvironment.
    Zhang LP; Zhang MY; Liu WJ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6419-6428. PubMed ID: 31378880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dormancy Stems the Tide of Chemotherapy.
    Pal D; Heidenreich O; Vormoor J
    Cancer Cell; 2016 Dec; 30(6):825-826. PubMed ID: 27960078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.